Singapore markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
174.41-5.48 (-3.05%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close179.89
Open177.01
Bid174.00 x 1000
Ask174.29 x 800
Day's range170.51 - 179.58
52-week range59.29 - 331.68
Volume2,876,980
Avg. volume3,752,312
Market cap12.923B
Beta (5Y monthly)1.55
PE ratio (TTM)N/A
EPS (TTM)-9.51
Earnings date09 Aug 2021 - 13 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est258.00
  • Covid jabs for billions of humans will earn their makers billions of dollars
    The Guardian

    Covid jabs for billions of humans will earn their makers billions of dollars

    Covid jabs for billions of humans will earn their makers billions of dollars. We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive

  • Got $10,000? Here Are Summer's Hottest Stocks to Buy
    Motley Fool

    Got $10,000? Here Are Summer's Hottest Stocks to Buy

    One scorching-hot company that you'll strongly want to consider adding to your portfolio this summer is social media superstar Pinterest (NYSE: PINS). To state the obvious, Pinterest benefited immensely from the pandemic. This meant spending more time posting about what interests them on Pinterest, as well as perusing the interests of others on the site.

  • How Does Novavax Stack Up Against Today's Vaccine Leaders?
    Motley Fool

    How Does Novavax Stack Up Against Today's Vaccine Leaders?

    Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have remained a step ahead of most potential coronavirus vaccine rivals. Novavax (NASDAQ: NVAX) plans to submit its coronavirus vaccine candidate for emergency authorization in various countries including the U.S. in the third quarter. Now the question is whether Novavax has what it takes to join leaders Pfizer and Moderna at the top.